Article R6123-94-2 of the French Public Health Code
I. – Establishments authorised for systemic medicinal treatments for cancer with designation B or C must have on site : 1° The organisation of a medical permanence at least by means of operational on-call duty; 2° A continuous surveillance unit; 3° An organisation allowing specialised and reinforced care for patients whose treatment of malignant haemopathy or malignant solid tumour by intensive chemotherapy results in foreseeable aplasia of more than eight…